HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN CHEMOKINE RECEPTOR CCR6

摘要

Aspects of this invention include fully human antibodies or fragments thereof that bind specifically to human CCR6 receptor. Such antibodies or fragments thereof can be used to treat disorders involving over function of the CCR6 receptor, including cancers, inflammatory diseases and fibrotic diseases. Other uses include detection of human CCR6 receptor in biological samples for diagnostic or evaluative purposes.